Compare PCVX & DNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCVX | DNP |
|---|---|---|
| Founded | 2013 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 3.8B |
| IPO Year | 2020 | N/A |
| Metric | PCVX | DNP |
|---|---|---|
| Price | $46.57 | $10.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $101.67 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 479.6K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.88% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.30 |
| Revenue | N/A | ★ $154,887,179.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $4.26 |
| Revenue Growth | N/A | ★ 3.30 |
| 52 Week Low | $27.66 | $8.69 |
| 52 Week High | $94.60 | $10.04 |
| Indicator | PCVX | DNP |
|---|---|---|
| Relative Strength Index (RSI) | 51.97 | 46.06 |
| Support Level | $43.78 | $10.00 |
| Resistance Level | $48.11 | $10.35 |
| Average True Range (ATR) | 1.99 | 0.11 |
| MACD | -0.49 | -0.02 |
| Stochastic Oscillator | 42.99 | 14.29 |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
DNP Select Income Fund Inc is a closed-ended investment management fund. The primary investment objectives of the fund are current income and long-term growth of income. Its secondary objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing in the public utility industry.